Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.
- Published In:
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 167, 106009 (2021)
- Authors:
- Wang, Dan, Cheng, Lu, Li, Jieru, Deng, Bochuan, Yan, Tiantian, Yue, Xin, Zhang, Jianfeng, Zhang, Bangzhi, Xie, Junqiu
- Database ID:
- RPEP-05849
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05849APA
Wang, Dan; Cheng, Lu; Li, Jieru; Deng, Bochuan; Yan, Tiantian; Yue, Xin; Zhang, Jianfeng; Zhang, Bangzhi; Xie, Junqiu. (2021). Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 167, 106009. https://doi.org/10.1016/j.ejps.2021.106009
MLA
Wang, Dan, et al. "Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021. https://doi.org/10.1016/j.ejps.2021.106009
RethinkPeptides
RethinkPeptides Research Database. "Peptide DR8 analogs alleviate pulmonary fibrosis via suppres..." RPEP-05849. Retrieved from https://rethinkpeptides.com/research/wang-2021-peptide-dr8-analogs-alleviate
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.